Brief: Cadrenal Therapeutics Says Matthew Szot Steps Down As CFO - SEC Filing
03/06/2026 22:34
BRIEF-Cadrenal Therapeutics Says Matthew Szot Steps Down As CFO - SEC Filing June 3 (Reuters) - Cadrenal Therapeutics Inc CVKD.O:
CADRENAL THERAPEUTICS - MATTHEW K. SZOT STEPS DOWN AS CFO EFFECTIVE MAY 28, 2026 - SEC FILING
CADRENAL THERAPEUTICS - APPOINTS QUANG X. PHAM AS INTERIM CFO AND INTERIM PRINCIPAL ACCOUNTING OFFICER - SEC FILING
Source text: [ID:n0001213900-26-064744]
Further company coverage: CVKD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cadrenal Therapeutics
See all newsCadrenal Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Cadrenal Therapeutics Q2 net loss narrows as operating expenses fall
Cadrenal Therapeutics Inc expected to post a loss of $1.42 a share - Earnings Preview
U.S. STOCKS ON THE MOVE-SpaceX, Sandisk, Salesforce
U.S. STOCKS ON THE MOVE-SpaceX, Sandisk, Marvell Technology